ESPR vs OMC · rev $332.3M vs rev $17.27B
Esperion Therapeutics Inc (ESPR) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
ESPR currently screens at market cap $816.9M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the ESPR and OMC stock pages for the full models.
Not investment advice.